Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2021 Filed Jun 4, 2021 20:12 UTC |
SCHIFF ANDREW NDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,250 | $0.00 Strike: $21.90 | $0.00 |
DisclosureSEC source: 0001209191-21-038459 · doc4.xml · derivative · entry 1 SCHIFF ANDREW N · CIK 0001172252 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,250 Underlying: Common Stock · 12,250 shares Expires 2031-06-02 F1 · derivative.exercise_date: This grant was made pursuant to the issuer's fifth amended and restated non-employee director compensation policy. F2 · derivative.exercise_date: The shares subject this option will vest in twelve equal monthly installments commencing July 3, 2021, subject to Reporting Person's continuous service through each such date. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 23:57 UTC |
Humphries William D.Director
|
GrantRestricted Stock Units · Derivative | 3,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-038446 · doc4.xml · derivative · entry 2 Humphries William D. · CIK 0001674278 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,356 Underlying: Common Stock · 3,356 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F1 · derivative.exercise_date: This grant was made pursuant to the issuer's fifth amended and restated non-employee director compensation policy. F4 · derivative.exercise_date: The shares underlying these restricted stock units will vest on June 3, 2022, subject to the Reporting Person's continuous service through such date. F4 · derivative.expiration_date: The shares underlying these restricted stock units will vest on June 3, 2022, subject to the Reporting Person's continuous service through such date. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 23:57 UTC |
Humphries William D.Director
|
GrantStock Option (Right to Buy) · Derivative | 12,250 | $0.00 Strike: $21.90 | $0.00 |
DisclosureSEC source: 0001209191-21-038446 · doc4.xml · derivative · entry 1 Humphries William D. · CIK 0001674278 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,250 Underlying: Common Stock · 12,250 shares Expires 2031-06-02 F1 · derivative.exercise_date: This grant was made pursuant to the issuer's fifth amended and restated non-employee director compensation policy. F2 · derivative.exercise_date: The shares subject this option will vest in twelve equal monthly installments commencing July 3, 2021, subject to Reporting Person's continuous service through each such date. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 23:52 UTC |
Ali-Jackson KamilChief Legal Officer
|
SaleCommon Stock | 9,492 | $21.96 | $208,420.59 |
DisclosureSEC source: 0001209191-21-038442 · doc4.xml · nonDerivative · entry 1 Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,196 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021. F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.57 to $22.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 23:55 UTC |
GOWEN MAXINEDirector
|
GrantRestricted Stock Units · Derivative | 3,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-038444 · doc4.xml · derivative · entry 2 GOWEN MAXINE · CIK 0001280044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,356 Underlying: Common Stock · 3,356 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F1 · derivative.exercise_date: This grant was made pursuant to the issuer's fifth amended and restated non-employee director compensation policy. F4 · derivative.exercise_date: The shares underlying these restricted stock units will vest on June 3, 2022, subject to the Reporting Person's continuous service through such date. F4 · derivative.expiration_date: The shares underlying these restricted stock units will vest on June 3, 2022, subject to the Reporting Person's continuous service through such date. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 23:55 UTC |
GOWEN MAXINEDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,250 | $0.00 Strike: $21.90 | $0.00 |
DisclosureSEC source: 0001209191-21-038444 · doc4.xml · derivative · entry 1 GOWEN MAXINE · CIK 0001280044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,250 Underlying: Common Stock · 12,250 shares Expires 2031-06-02 F1 · derivative.exercise_date: This grant was made pursuant to the issuer's fifth amended and restated non-employee director compensation policy. F2 · derivative.exercise_date: The shares subject this option will vest in twelve equal monthly installments commencing July 3, 2021, subject to Reporting Person's continuous service through each such date. Read SEC document |
| June 03, 2021 Filed Jun 5, 2021 00:02 UTC |
MILANO VINCENTDirector
|
GrantRestricted Stock Units · Derivative | 3,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-038450 · doc4.xml · derivative · entry 2 MILANO VINCENT · CIK 0001187159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,356 Underlying: Common Stock · 3,356 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F1 · derivative.exercise_date: This grant was made pursuant to the issuer's fifth amended and restated non-employee director compensation policy. F4 · derivative.exercise_date: The shares underlying these restricted stock units will vest on June 3, 2022, subject to the Reporting Person's continuous service through such date. F4 · derivative.expiration_date: The shares underlying these restricted stock units will vest on June 3, 2022, subject to the Reporting Person's continuous service through such date. Read SEC document |
| June 03, 2021 Filed Jun 5, 2021 00:02 UTC |
MILANO VINCENTDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,250 | $0.00 Strike: $21.90 | $0.00 |
DisclosureSEC source: 0001209191-21-038450 · doc4.xml · derivative · entry 1 MILANO VINCENT · CIK 0001187159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,250 Underlying: Common Stock · 12,250 shares Expires 2031-06-02 F1 · derivative.exercise_date: This grant was made pursuant to the issuer's fifth amended and restated non-employee director compensation policy. F2 · derivative.exercise_date: The shares subject this option will vest in twelve equal monthly installments commencing July 3, 2021, subject to Reporting Person's continuous service through each such date. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 20:07 UTC |
Powell Andrew Kenneth WilliamDirector
|
GrantRestricted Stock Units · Derivative | 3,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-038455 · doc4.xml · derivative · entry 2 Powell Andrew Kenneth William · CIK 0001304113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,356 Underlying: Common Stock · 3,356 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F1 · derivative.exercise_date: This grant was made pursuant to the issuer's fifth amended and restated non-employee director compensation policy. F4 · derivative.exercise_date: The shares underlying these restricted stock units will vest on June 3, 2022, subject to the Reporting Person's continuous service through such date. F4 · derivative.expiration_date: The shares underlying these restricted stock units will vest on June 3, 2022, subject to the Reporting Person's continuous service through such date. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 20:07 UTC |
Powell Andrew Kenneth WilliamDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,250 | $0.00 Strike: $21.90 | $0.00 |
DisclosureSEC source: 0001209191-21-038455 · doc4.xml · derivative · entry 1 Powell Andrew Kenneth William · CIK 0001304113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,250 Underlying: Common Stock · 12,250 shares Expires 2031-06-02 F1 · derivative.exercise_date: This grant was made pursuant to the issuer's fifth amended and restated non-employee director compensation policy. F2 · derivative.exercise_date: The shares subject this option will vest in twelve equal monthly installments commencing July 3, 2021, subject to Reporting Person's continuous service through each such date. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 20:09 UTC |
Reasons Bryan M.Director
|
GrantRestricted Stock Units · Derivative | 3,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-038457 · doc4.xml · derivative · entry 2 Reasons Bryan M. · CIK 0001553489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,356 Underlying: Common Stock · 3,356 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F1 · derivative.exercise_date: This grant was made pursuant to the issuer's fifth amended and restated non-employee director compensation policy. F4 · derivative.exercise_date: The shares underlying these restricted stock units will vest on June 3, 2022, subject to the Reporting Person's continuous service through such date. F4 · derivative.expiration_date: The shares underlying these restricted stock units will vest on June 3, 2022, subject to the Reporting Person's continuous service through such date. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 20:09 UTC |
Reasons Bryan M.Director
|
GrantStock Option (Right to Buy) · Derivative | 12,250 | $0.00 Strike: $21.90 | $0.00 |
DisclosureSEC source: 0001209191-21-038457 · doc4.xml · derivative · entry 1 Reasons Bryan M. · CIK 0001553489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,250 Underlying: Common Stock · 12,250 shares Expires 2031-06-02 F1 · derivative.exercise_date: This grant was made pursuant to the issuer's fifth amended and restated non-employee director compensation policy. F2 · derivative.exercise_date: The shares subject this option will vest in twelve equal monthly installments commencing July 3, 2021, subject to Reporting Person's continuous service through each such date. Read SEC document |
| June 03, 2021 Filed Jun 5, 2021 00:05 UTC |
Molineaux Christopher P.Director
|
GrantRestricted Stock Units · Derivative | 3,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-038452 · doc4.xml · derivative · entry 2 Molineaux Christopher P. · CIK 0001654773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,356 Underlying: Common Stock · 3,356 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F1 · derivative.exercise_date: This grant was made pursuant to the issuer's fifth amended and restated non-employee director compensation policy. F4 · derivative.exercise_date: The shares underlying these restricted stock units will vest on June 3, 2022, subject to the Reporting Person's continuous service through such date. F4 · derivative.expiration_date: The shares underlying these restricted stock units will vest on June 3, 2022, subject to the Reporting Person's continuous service through such date. Read SEC document |
| June 03, 2021 Filed Jun 5, 2021 00:05 UTC |
Molineaux Christopher P.Director
|
GrantStock Option (Right to Buy) · Derivative | 12,250 | $0.00 Strike: $21.90 | $0.00 |
DisclosureSEC source: 0001209191-21-038452 · doc4.xml · derivative · entry 1 Molineaux Christopher P. · CIK 0001654773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,250 Underlying: Common Stock · 12,250 shares Expires 2031-06-02 F1 · derivative.exercise_date: This grant was made pursuant to the issuer's fifth amended and restated non-employee director compensation policy. F2 · derivative.exercise_date: The shares subject this option will vest in twelve equal monthly installments commencing July 3, 2021, subject to Reporting Person's continuous service through each such date. Read SEC document |
| June 03, 2021 Filed Jun 5, 2021 00:00 UTC |
Mehra AnandDirector
|
GrantRestricted Stock Units · Derivative | 3,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-038448 · doc4.xml · derivative · entry 2 Mehra Anand · CIK 0001590102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,356 Underlying: Common Stock · 3,356 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F1 · derivative.exercise_date: This grant was made pursuant to the issuer's fifth amended and restated non-employee director compensation policy. F4 · derivative.exercise_date: The shares underlying these restricted stock units will vest on June 3, 2022, subject to the Reporting Person's continuous service through such date. F4 · derivative.expiration_date: The shares underlying these restricted stock units will vest on June 3, 2022, subject to the Reporting Person's continuous service through such date. Read SEC document |
| June 03, 2021 Filed Jun 5, 2021 00:00 UTC |
Mehra AnandDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,250 | $0.00 Strike: $21.90 | $0.00 |
DisclosureSEC source: 0001209191-21-038448 · doc4.xml · derivative · entry 1 Mehra Anand · CIK 0001590102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,250 Underlying: Common Stock · 12,250 shares Expires 2031-06-02 F1 · derivative.exercise_date: This grant was made pursuant to the issuer's fifth amended and restated non-employee director compensation policy. F2 · derivative.exercise_date: The shares subject this option will vest in twelve equal monthly installments commencing July 3, 2021, subject to Reporting Person's continuous service through each such date. Read SEC document |
| June 02, 2021 Filed Jun 2, 2021 21:45 UTC |
Monahan JosephChief Scientific Officer
|
SaleCommon Stock | 3,550 | $22.31 | $79,205.47 |
DisclosureSEC source: 0001209191-21-037478 · doc4.xml · nonDerivative · entry 3 Monahan Joseph · CIK 0001861790 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,342 F2 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on June 1, 2021 pursuant to preexisting sell-to-cover elections. F4 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.03 to $22.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 02, 2021 Filed Jun 2, 2021 21:45 UTC |
Monahan JosephChief Scientific Officer
|
SaleCommon Stock | 18,240 | $21.50 | $392,231.14 |
DisclosureSEC source: 0001209191-21-037478 · doc4.xml · nonDerivative · entry 2 Monahan Joseph · CIK 0001861790 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,892 F2 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on June 1, 2021 pursuant to preexisting sell-to-cover elections. F3 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.03 to $22.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 01:47 UTC |
Ali-Jackson KamilChief Legal Officer
|
SaleCommon Stock | 2,387 | $22.31 | $53,256.83 |
DisclosureSEC source: 0001209191-21-037482 · doc4.xml · nonDerivative · entry 7 Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,688 F7 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on June 1, 2021 pursuant to preexisting sell-to-cover elections. F9 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.07 to $22.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 01:47 UTC |
Ali-Jackson KamilChief Legal Officer
|
SaleCommon Stock | 12,732 | $21.51 | $273,822.03 |
DisclosureSEC source: 0001209191-21-037482 · doc4.xml · nonDerivative · entry 6 Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,075 F7 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on June 1, 2021 pursuant to preexisting sell-to-cover elections. F8 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.06 to $22.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 01:47 UTC |
Ali-Jackson KamilChief Legal Officer
|
SaleCommon Stock | 2,517 | $22.32 | $56,173.15 |
DisclosureSEC source: 0001209191-21-037482 · doc4.xml · nonDerivative · entry 5 Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,807 F2 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021. F6 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.06 to $22.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 01:47 UTC |
Ali-Jackson KamilChief Legal Officer
|
SaleCommon Stock | 12,483 | $21.50 | $268,411.96 |
DisclosureSEC source: 0001209191-21-037482 · doc4.xml · nonDerivative · entry 4 Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,324 F2 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021. F5 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.03 to $22.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 01:49 UTC |
Gordon David N.Chief Medical Officer
|
SaleCommon Stock | 6,800 | $22.26 | $151,401.32 |
DisclosureSEC source: 0001209191-21-037484 · doc4.xml · nonDerivative · entry 5 Gordon David N. · CIK 0001751167 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,078 F5 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on June 1, 2021 pursuant to preexisting sell-to-cover elections. F7 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.01 to $22.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 01:49 UTC |
Gordon David N.Chief Medical Officer
|
SaleCommon Stock | 31,114 | $21.50 | $668,807.88 |
DisclosureSEC source: 0001209191-21-037484 · doc4.xml · nonDerivative · entry 4 Gordon David N. · CIK 0001751167 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,878 F5 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on June 1, 2021 pursuant to preexisting sell-to-cover elections. F6 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.01 to $21.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 01:43 UTC |
Ruffo FrankChief Financial Officer
|
SaleCommon Stock | 2,450 | $22.30 | $54,635.00 |
DisclosureSEC source: 0001209191-21-037475 · doc4.xml · nonDerivative · entry 3 Ruffo Frank · CIK 0001654450 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,872 F2 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on June 1, 2021 pursuant to preexisting sell-to-cover elections. F4 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.06 to $22.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 01:43 UTC |
Ruffo FrankChief Financial Officer
|
SaleCommon Stock | 12,587 | $21.51 | $270,747.63 |
DisclosureSEC source: 0001209191-21-037475 · doc4.xml · nonDerivative · entry 2 Ruffo Frank · CIK 0001654450 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,322 F2 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on June 1, 2021 pursuant to preexisting sell-to-cover elections. F3 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.06 to $22.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 01:41 UTC |
Walker NealDirector · President and CEO
|
SaleCommon Stock | 5,517 | $22.30 | $123,038.48 |
DisclosureSEC source: 0001209191-21-037473 · doc4.xml · nonDerivative · entry 3 Walker Neal · CIK 0001604457 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,232,182 F2 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on June 1, 2021 pursuant to preexisting sell-to-cover elections. F4 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.01 to $22.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 01:41 UTC |
Walker NealDirector · President and CEO
|
SaleCommon Stock | 27,743 | $21.51 | $596,696.44 |
DisclosureSEC source: 0001209191-21-037473 · doc4.xml · nonDerivative · entry 2 Walker Neal · CIK 0001604457 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,237,699 F2 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on June 1, 2021 pursuant to preexisting sell-to-cover elections. F3 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.005 to $21.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 21:45 UTC |
Monahan JosephChief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-037478 · doc4.xml · derivative · entry 5 Monahan Joseph · CIK 0001861790 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F5 · derivative.exercise_date: The shares underlying these restricted stock units vested on June 1, 2021. F5 · derivative.expiration_date: The shares underlying these restricted stock units vested on June 1, 2021. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 21:45 UTC |
Monahan JosephChief Scientific Officer
|
Exercise / conversionCommon Stock | 50,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-037478 · doc4.xml · nonDerivative · entry 1 Monahan Joseph · CIK 0001861790 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,132 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 01:47 UTC |
Ali-Jackson KamilChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 33,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-037482 · doc4.xml · derivative · entry 8 Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,189 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F10 · derivative.exercise_date: The shares underlying these restricted stock units vested in two equal annual installments beginning on June 1, 2020. F10 · derivative.expiration_date: The shares underlying these restricted stock units vested in two equal annual installments beginning on June 1, 2020. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 01:47 UTC |
Ali-Jackson KamilChief Legal Officer
|
SaleCommon Stock | 5,254 | $23.57 | $123,851.49 |
DisclosureSEC source: 0001209191-21-037482 · doc4.xml · nonDerivative · entry 3 Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,807 F2 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021. F4 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $23.27 to $23.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 01:47 UTC |
Ali-Jackson KamilChief Legal Officer
|
SaleCommon Stock | 9,746 | $22.72 | $221,447.64 |
DisclosureSEC source: 0001209191-21-037482 · doc4.xml · nonDerivative · entry 2 Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,061 F2 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021. F3 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.25 to $23.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 01:47 UTC |
Ali-Jackson KamilChief Legal Officer
|
Exercise / conversionCommon Stock | 33,189 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-037482 · doc4.xml · nonDerivative · entry 1 Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,807 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 01:49 UTC |
Gordon David N.Chief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 87,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-037484 · doc4.xml · derivative · entry 6 Gordon David N. · CIK 0001751167 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 87,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F8 · derivative.exercise_date: The shares underlying these restricted stock units vested in two equal annual installments beginning on June 1, 2020. F8 · derivative.expiration_date: The shares underlying these restricted stock units vested in two equal annual installments beginning on June 1, 2020. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 01:49 UTC |
Gordon David N.Chief Medical Officer
|
SaleCommon Stock | 4,885 | $23.57 | $115,141.89 |
DisclosureSEC source: 0001209191-21-037484 · doc4.xml · nonDerivative · entry 3 Gordon David N. · CIK 0001751167 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,992 F2 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021. F4 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $23.33 to $23.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 01:49 UTC |
Gordon David N.Chief Medical Officer
|
SaleCommon Stock | 9,115 | $22.71 | $207,023.53 |
DisclosureSEC source: 0001209191-21-037484 · doc4.xml · nonDerivative · entry 2 Gordon David N. · CIK 0001751167 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,877 F2 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021. F3 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.24 to $23.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 01:49 UTC |
Gordon David N.Chief Medical Officer
|
Exercise / conversionCommon Stock | 87,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-037484 · doc4.xml · nonDerivative · entry 1 Gordon David N. · CIK 0001751167 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,992 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 01:43 UTC |
Ruffo FrankChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 33,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-037475 · doc4.xml · derivative · entry 4 Ruffo Frank · CIK 0001654450 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,189 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F5 · derivative.exercise_date: The shares underlying these restricted stock units vested in two equal annual installments beginning on June 1, 2020. F5 · derivative.expiration_date: The shares underlying these restricted stock units vested in two equal annual installments beginning on June 1, 2020. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 01:43 UTC |
Ruffo FrankChief Financial Officer
|
Exercise / conversionCommon Stock | 33,189 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-037475 · doc4.xml · nonDerivative · entry 1 Ruffo Frank · CIK 0001654450 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,909 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 01:41 UTC |
Walker NealDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 73,015 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-037473 · doc4.xml · derivative · entry 4 Walker Neal · CIK 0001604457 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 73,015 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F5 · derivative.exercise_date: The shares underlying these restricted stock units vested in two equal annual installments beginning on June 1, 2020. F5 · derivative.expiration_date: The shares underlying these restricted stock units vested in two equal annual installments beginning on June 1, 2020. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 01:41 UTC |
Walker NealDirector · President and CEO
|
Exercise / conversionCommon Stock | 73,015 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-037473 · doc4.xml · nonDerivative · entry 1 Walker Neal · CIK 0001604457 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,265,442 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. Read SEC document |
| May 07, 2021 Filed May 7, 2021 22:28 UTC |
Ali-Jackson KamilChief Legal Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,416 | $0.00 Strike: $10.66 | $0.00 |
DisclosureSEC source: 0001209191-21-031038 · doc4.xml · derivative · entry 8 Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,416 shares Expires 2025-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option is fully vested. Read SEC document |
| May 07, 2021 Filed May 7, 2021 22:28 UTC |
Ali-Jackson KamilChief Legal Officer
|
SaleCommon Stock | 2,100 | $23.99 | $50,376.06 |
DisclosureSEC source: 0001209191-21-031038 · doc4.xml · nonDerivative · entry 6 Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,618 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021. F5 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $23.83 to $24.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 07, 2021 Filed May 7, 2021 22:28 UTC |
Ali-Jackson KamilChief Legal Officer
|
SaleCommon Stock | 3,316 | $23.23 | $77,015.76 |
DisclosureSEC source: 0001209191-21-031038 · doc4.xml · nonDerivative · entry 5 Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,718 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021. F4 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.83 to $23.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 07, 2021 Filed May 7, 2021 22:28 UTC |
Ali-Jackson KamilChief Legal Officer
|
Exercise / conversionCommon Stock | 5,416 | $10.66 | $57,734.56 |
DisclosureSEC source: 0001209191-21-031038 · doc4.xml · nonDerivative · entry 4 Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,034 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2021 Filed May 7, 2021 22:28 UTC |
Ali-Jackson KamilChief Legal Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $10.66 | $0.00 |
DisclosureSEC source: 0001209191-21-031038 · doc4.xml · derivative · entry 7 Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,416 Underlying: Common Stock · 20,416 shares Expires 2025-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option is fully vested. Read SEC document |
| May 06, 2021 Filed May 7, 2021 22:28 UTC |
Ali-Jackson KamilChief Legal Officer
|
SaleCommon Stock | 3,102 | $23.86 | $74,015.58 |
DisclosureSEC source: 0001209191-21-031038 · doc4.xml · nonDerivative · entry 3 Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,618 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021. F3 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $23.79 to $23.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 06, 2021 Filed May 7, 2021 22:28 UTC |
Ali-Jackson KamilChief Legal Officer
|
SaleCommon Stock | 11,898 | $23.32 | $277,437.56 |
DisclosureSEC source: 0001209191-21-031038 · doc4.xml · nonDerivative · entry 2 Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,720 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021. F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.79 to $23.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 06, 2021 Filed May 7, 2021 22:28 UTC |
Ali-Jackson KamilChief Legal Officer
|
Exercise / conversionCommon Stock | 15,000 | $10.66 | $159,900.00 |
DisclosureSEC source: 0001209191-21-031038 · doc4.xml · nonDerivative · entry 1 Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.